Disposal Update

Summary by AI BETAClose X

Palace Capital plc has exchanged contracts for the sale of its investment property at Broad Street Plaza, Halifax, for £9.9 million, which is 8.7% above its September 2025 valuation and represents a 14.9% net initial yield, with completion expected shortly, marking the disposal of all its Halifax interests following a prior £4.8 million sale of Units 5&6b. Additionally, the company has completed the sale of unit 3A, St. James' Gate, Newcastle, for £0.59 million.

Disclaimer*

Palace Capital PLC
09 February 2026
 

9 February 2026

Palace Capital plc

("Palace Capital" or the "Company")

DISPOSAL UPDATE

The Company has unconditionally exchanged on the sale of its investment property at Broad Street Plaza, Halifax for £9.9 million at a 14.9.% net initial yield ("NIY"). The sale price is 8.7% ahead of the September 2025 valuation. Completion is expected in the next few weeks.

The Company announced in April 2025 the disposal of Units 5&6b, Broad Street Plaza, Halifax, on a long leasehold interest for £4.8 million to Calderdale and Huddersfield NHS Foundation Trust, at a 7.5% NIY. On completion of the disposal announced today, the Company will have disposed of all of its interests in Halifax.

The Company has also exchanged and completed on the sale of unit 3A, St. James' Gate, Newcastle for £0.59 million.

Further updates will be made in due course.

 

Palace Capital plc
Christian Kappelhoff-Wulff, Non-Executive Chairman
ckw@palacecapitalplc.com

Financial PR
FTI Consulting
Dido Laurimore / Andrew Davies
Tel: +44 (0)20 3727 1000
palacecapital@fticonsulting.com

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings